2023-08-10 06:34:05 ET
- Veru press release ( NASDAQ: VERU ): Q3 GAAP EPS of $0.07 beats by $0.27 .
- Revenue of $3.34M (-65.2% Y/Y) misses by $6.88M .
For further details see:
Veru GAAP EPS of $0.07 beats by $0.27, revenue of $3.34M misses by $6.88M2023-08-10 06:34:05 ET
For further details see:
Veru GAAP EPS of $0.07 beats by $0.27, revenue of $3.34M misses by $6.88MMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...
MIAMI, FL, June 18, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced acute respiratory distress syndrome, today announced th...